Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

66. Johnson P N, Miller J L. Small patients, big problems? Pediatric primer for the nonpediatric pharmacist. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2019; 76 : 1451-1452

67. Blackmer A B, Siu A, Thornton A, Johnson P N, Nichols K R, Hagemann T M. Academic Careers in Pediatric Pharmacy: Part 2-Academic Advancement. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 183-193

68. Miller J L, Ernst K, Neely S, Stephens K, Barker P, Skrepnek G H, Johnson P N. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. Journal of opioid management. 2019; 15 : 159-167

69. Siu A, Blackmer A B, Thornton A M, Johnson P N, Nichols K R, Hagemann T M. Overview and Preparation Guide for Academic Careers in Pediatric Pharmacy, Part 1: Career as a Pediatric Pharmacy Practice Faculty Member. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 79-89

70. Capino A C, Johnson P N, Williams P K, Anderson M P, Bedwell S, Miller J L. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 148-155

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


4. Society of Critical Care Medicine Presidential Citation. Date: 2022.


5. Oklahoma Foundation for Excellence. Oklahoma Medal for Excellence Finalist in Teaching and Administration. Date: 2022.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results